EUVIMED · CrossrefJournal
JCO Oncology Advances
ISSN 2994-9750 · American Society of Clinical Oncology (ASCO)
Latest articles
Immersive Virtual Reality for the Management of Chemotherapy-Induced Distress in Patients With Cancer
Gemcitabine Intravesical Drug-Releasing System in Bacillus Calmette-Guérin–Unresponsive Papillary-Only High-Risk Non–Muscle-Invasive Bladder Cancer: 12-Month Update From SunRISe-1 Cohort 4
Concordance of Somatic Whole-Exome Sequencing and Germline Genotyping of DPYD to Screen for Dihydropyrimidine Dehydrogenase Deficiency
GemSarc: A Novel Predictive Gene Signature for Gemcitabine Efficacy in Advanced Bone and Soft Tissue Sarcomas
NRG1 Fusion–Driven Pancreatic Cancer: Real-World Detection Across a Japanese National Database and International Genomic Datasets, With an Illustrative RNA-Confirmed Case
Neoadjuvant Lazertinib With or Without Chemotherapy in Patients With Resectable EGFR -Mutant Non–Small Cell Lung Cancer (NeoLazer): A Randomized, Multicenter, Phase II Trial
Does Maintenance Therapy Improve Survival of Patients With Intermediate-Risk Rhabdomyosarcoma Treated With VAC/VI Regimen? A Report From the Children's Oncology Group
Single-Arm Combined Phase I/II Study Evaluating Limb Cryocompression to Prevent Chemotherapy-Induced Peripheral Neuropathy in Patients Receiving Taxane-Based Chemotherapy
Racial, Ethnic, Sex, and Subspecialty Demographic Composition of Initial Fellow of the ASCO Recipients From 2007 Through 2024
Patterns of Patient-Reported Awareness About Early-Onset Cancer-Related Infertility Risk
Phase I Study of B440, an Oral Wilms' Tumor 1 Cancer Vaccine Using a Bifidobacterium Vector, in Patients With Metastatic Urothelial Cancer
Intismeran Autogene Therapy: An End-to-End Pathway From Tumor Tissue to Individualized Neoantigen Treatment for Patients With Cancer
Efficacy and Safety of Investigational Treatments in Contemporary Early-Phase Clinical Trials for Japanese Gynecologic Cancers: A Single-Institution Retrospective Analysis
Tumor Lineage–Specific Disparities in Access to Genome-Matched Therapies Among Adolescents and Young Adults in Japan: A Nationwide Genomic Profiling Study
CAST-AI: Cystectomy After Systemic Therapy With Antibody-Drug Conjugate and Immunotherapy
Acalabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone as First-Line Therapy for Patients With Diffuse Large B-Cell Lymphoma
Planning, Reporting, and Selective Disclosure of Quality-of-Life End Points in Phase III Genitourinary Cancer Trials
Precision Oncology for Solid Tumor Malignancies in the Rural United States: A Scoping Review
Unplanned Hospitalization and Percutaneous Endoscopic Gastrostomy Tube Use for Head and Neck Cancer
RMS13: A Phase II Trial Using Risk-Adapted Proton Beam Radiation and Surgery With Addition of Antiangiogenic Maintenance Chemotherapy in Intermediate-Risk Rhabdomyosarcoma
Prospective Phase II Trial of Cemiplimab Plus Gemcitabine in SWItch/Sucrose Nonfermentable-Altered Metastatic Pancreatic Ductal Adenocarcinoma
Erratum: NEO-RT Organ Preservation Trial for Early Rectal Cancer: CCTG CO.32 Phase III Randomized Trial of Neoadjuvant Chemotherapy, Excision and Observation Versus Chemoradiotherapy
Lynch Syndrome in the General Population: Clinical Phenotype of PMS2 Pathogenic Variants
Who Can Benefit From a Cancer Genetic Evaluation? Considerations for Genetic Risk Evaluation and Testing Based on Tumor Type and Pathology
Patterns of Care and Outcomes of Neoadjuvant Chemotherapy or Primary Surgery in Stage III-IV Ovarian Cancer: An Ancillary Study of GOG 262
Evaluating Underrepresentation in Cancer Clinical Trial Enrollment Across Three National Cancer Institute–Designated Cancer Centers: A Retrospective Demographic Study
Survival Outcomes Based on Line of Therapy and Treatment Trends With Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
Vincristine-Induced Neuropathy in UKALL 2011: Effects of Vincristine/Dexamethasone Pulse Omission and Prospective Gait Outcomes
Pilot Study of Gemcitabine, Nab-Paclitaxel, and Ciprofloxacin in Patients With Advanced Pancreatic Ductal Adenocarcinoma
Cervical Cancer Mortality Trends and Avoided Deaths in 48 Countries With Longitudinal Surveillance Data From GLOBOCAN, 1950-2018
EUVIMED